Russian Pharma: Road map

21 May 2013

Shulyak SergeyGeneral DirectorDSM Group

Growth of the pharmaceutical market has stabilized

Source: DSM Group, audit of pharmaceutical market RF

Growth of the pharmaceutical market in dollars

Source: DSM Group, audit of pharmaceutical market RF

Turnover of drugs`market is positive in EURO

Source: DSM Group, audit of pharmaceutical market RF

Commercial segment in recent years growing much faster

Source: DSM Group, audit of pharmaceutical market RF

Retail segment is 74% Russian pharma market

Source: DSM Group, audit of pharmaceutical market RF

The largest contribution to the growth of pharma market - structural change in favor of expensive drugs

Source: DSM Group, audit of pharmaceutical market RF

Russian pharmaceutical market: a lot or a little?

Source: DSM Group, Rating: Expert 400 for 2012

Manufacturing of pharmaceutical products and medical devices in Russia

Source: GKS

Retail trade turnover

Source: GKS, DSM

Per capita consumption of medicines in Russia(pharma market)

Source: DSM Group, audit of pharmaceutical market RF

Per capita consumption of medicines are rising in direct proportion to income population

Source: DSM Group, GKS

Domestic products occupy 24% in terms of value, 60% in terms of volume

Source: DSM Group, audit of pharmaceutical market RF, 2012

Localized products occupy 32% in terms of value, 68% in terms of volume

Source: DSM Group, audit of pharmaceutical market RF, 2012

Forecast 2013

Source: DSM Group, audit of pharmaceutical market RF

Take coffee please!

www.dsm.ru